Home/Filings/4/0001209191-21-067905
4//SEC Filing

Hamm John M. 4

Accession 0001209191-21-067905

CIK 0001087294other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 5:15 PM ET

Size

4.5 KB

Accession

0001209191-21-067905

Insider Transaction Report

Form 4
Period: 2021-11-23
Hamm John M.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2021-11-23$2.35/sh+3,800$8,9306,800 total

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1
  • filerCIK 0001870439

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:15 PM ET
Size
4.5 KB